疫苗前沿 | mRNA疫苗再度开辟新战场，挑战潜伏性病毒

参考资料：

[1] Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine. Retrieved January 5, 2022, from https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-sign-new-global-collaboration-agreement

[2] MODERNA ANNOUNCES FIRST PARTICIPANT DOSED IN PHASE 1 STUDY OF ITS MRNA EPSTEIN-BARR VIRUS (EBV) VACCINE. Retrieved January 5, 2022, from https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-Phase-1-Study-of-its-mRNA-Epstein-Barr-Virus-EBV-Vaccine/default.aspx

来源：药明康德

END 

本公众号所有转载文章系出于传递更多信息之目的，且明确注明来源和作者，不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。所有文章仅代表作者观点，不代表本站立场。

欢迎留言、讨论、转发，同时，我们也向业内人士长期征稿，点击主菜单下方“联系我们”，获取方式！